BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:25 PM
 | 
Apr 30, 2010
 |  BC Extra  |  Company News

Avanir submits Zenvia complete response

Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) submitted a complete response to a 2006 FDA approvable letter for Zenvia dextromethorphan/quinidine to treat pseudobulbar affect (PBA). Avanir said the...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >